Training in Vaccine & Immune Therapeutics

描述（由申请人提供）：为了响应NIAID对疫苗研究和开发领域专业知识日益增长的需求，宾夕法尼亚大学的医学研究界提议建立疫苗和免疫治疗学培训计划。大学校园在疫苗发现，开发和测试许多目前获得许可的疫苗方面有着重要的贡献历史，并制定了一项重要的计划，与学员分享这一专业知识。培训人员来自宾夕法尼亚大学的Wistar研究所以及费城儿童医院，这些机构毗邻宾夕法尼亚大学校园。该培训计划最初将支持3名学生中的博士或MD/Ph.D或V.M.D./博士研究生1名，博士后1名。该应用程序将允许受训人员在21个实验室中的一个进行培训，这些实验室由积极性很高的首席研究员领导，他们在疫苗和免疫治疗研究的重要领域建立了培训记录。与此T32应用程序相关的培训师是根据他们在疫苗/免疫治疗相关研究方面的良好成就记录选择的，这些成就记录可以通过他们的声誉，强大的出版记录和赠款资金，以及少数民族培训和招聘的强大集团历史以及参与学生培训的强有力的评论来证明。该培训计划将是新定义的基因治疗和疫苗（GTV）研究生培训计划的一部分，该计划是细胞和分子生物学研究生计划（CAMB）的6个计划之一。与宾夕法尼亚大学最大的生物医学研究生培训项目CAMB的合作将促进学生的培训和校园的稳定。此外，与行业的独特外部关系使学生和博士后学员能够以高度正式的方式在一些国家的精英公司疫苗环境中体验培训。GTV培训方案设有正式机制，在培训补助金支助期间和之后监测受训者的进展情况。专门的课程已经开发并到位，以确保疫苗和免疫治疗的重要基础。一个特殊的教师小组已经组装，以协助这一进程。重要的是，培训计划有正式的机制来监督培训人员，并确保学员和教师的高水平成就。

DESCRIPTION (provided by applicant): In response to the stated NIAID growing need for expertise in the area of vaccine research and development, the medical research community at the University of Pennsylvania proposes to establish a training program in Vaccines and Immune Therapeutics. The University Campus has an important history of contribution to vaccine discovery, development and testing of many currently licensed vaccines and has developed an important program to share this expertise with trainees. Trainers are drawn from the Wistar Institute, University of Pennsylvania, as well as the Children's Hospital of Philadelphia, which are institutions located contiguously on the University of Pennsylvania campus. The training program would initially support 3 students among a pool of Ph.D or MD/Ph.D or V.M.D./Ph.D candidates, as well as 1 post doctoral fellow. This application would allow the trainees to train in one of 21 laboratories directed by highly motivated Principal Investigators who have established records in training in important areas of Vaccine and Immune Therapy research. The trainers associated with this T32 application were selected based on their well established record of accomplishment in Vaccine/Immune Therapy-related research as evidenced by their reputations, strong publication records and grant funding, as well as a strong group history of minority training and recruitment and strong reviews for participation in student training. This training program will be part of the newly defined graduate training program in Gene Therapy and Vaccines (GTV), which is one of the 6 programs in the Cell and Molecular Biology Graduate Program (CAMB). The affiliation with CAMB, the largest biomedical graduate training program at the University of Pennsylvania, will facilitate student training and stability on the campus. Furthermore a unique externship relationship with industry allows students and postdoctoral trainees to experience training at some of the nations elite company vaccine settings in a highly formalized manner. The GTV training program has formal mechanisms to monitor trainees' progress both during and after their training grant support. Specialized courses have been developed and are in place to ensure significant grounding in Vaccines and Immune Therapy. An exceptional group of faculty has been assembled to assist in this process. Importantly, the training program has formal mechanisms to monitor trainers and to ensure a high level of accomplishment for trainees and faculty alike.